Company Directory > Digital Health > Celito Tech, Inc.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Celito Tech, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Celito Tech is a technology-enabled life sciences consulting firm that provides standardized platforms and accelerators to help biotech and pharmaceutical organizations streamline operations, reduce risk, and scale from early research through commercialization. The company offers specialized expertise in clinical quality assurance, regulatory and audit readiness, medical affairs enablement, enterprise application management, cybersecurity, and cloud migration. Founded in 2019, Celito Tech focuses on bridging the gap between complex regulatory requirements and modern technology integration, including AI. The firm supports life sciences companies in navigating the demanding regulatory environment governing drug development, clinical trials, and manufacturing, ensuring that clients can focus on their core mission of developing life-saving therapies.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Life Sciences IT Consulting & Regulatory Services
SIZE & FINANCIALS
Employees:51-200
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Investors:Achieve Partners
0
CORPORATE STRUCTURE
Subsidiaries:Celito Tech India Pvt Ltd
Key Partnerships:Sarcomatrix Therapeutics (Strategic collaboration to advance clinical trials)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Vikas Kawatra - CEO and Co-Founder
Ravi Kumar Monangi - CTO and Co-Founder
Board Members:Jeet Mahal
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Celito Tech, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.